Literature DB >> 35936643

Urbach--Wiethe Disease: A Rare Cause of Bilateral Mesial Temporal Lobe Involvement and Cerebral Hemorrhage.

Hüseyin Nezih Özdemir1, Cem Çallı2, Figen Gökçay3, Ahmet Gökçay3.   

Abstract

Entities:  

Year:  2022        PMID: 35936643      PMCID: PMC9350792          DOI: 10.4103/aian.aian_832_21

Source DB:  PubMed          Journal:  Ann Indian Acad Neurol        ISSN: 0972-2327            Impact factor:   1.714


× No keyword cloud information.
Dear Editor, Two siblings born from consanguineous parents were admitted to our hospital with the complaint of seizures. The seizures were in the form of unresponsiveness attacks that lasted less than 1 min. Before these seizures, the patients described an aura with an unusual bad smell. No ictal motor phenomenon was described. The first patient was a 37-year-old man. In addition to the seizures, he also had behavioral changes. The patient was no longer afraid of animals that he used to fear. He had irritability and aggressive behaviors, as well as increased libido and hypersexuality. He had sex with multiple partners multiple times despite being married. In his past medical history, he had a putaminal hemorrhage at the age of 33, despite not having hypertension or an aneurysm [Figure 1a]. The patient also had hoarseness since early childhood. His neurological examination was normal. On physical examination, he had alopecia. There were multiple papules on the eyelid margins and the malar region (moniliform blepharosis) [Figure 1b]. Cranial magnetic resonance imaging (MRI) showed bilateral, symmetrical calcification of the hippocampus and parahippocampal regions, which had a hypointense appearance on T1 and Fluid-attenuated inversion recovery (FLAIR) sequences [Figure 1c and d]. Cranial MRI features were compatible with Urbach--Wiethe disease. Extracellular matrix protein 1 (ECM-1) gene mutation was shown by genetic testing. Electroencephalography (EEG) did not show any abnormalities.
Figure 1

(a) Putaminal hemorrhage on a brain computerized tomography image. (b) Moniliform blepharosis. (c) Bilateral amygdala calcification on a coronal FLAIR sequence. (d) Bilateral amygdala calcification on an axial T1 sequence

(a) Putaminal hemorrhage on a brain computerized tomography image. (b) Moniliform blepharosis. (c) Bilateral amygdala calcification on a coronal FLAIR sequence. (d) Bilateral amygdala calcification on an axial T1 sequence The second patient was a 23-year-old man. Although he did not have any neuropsychological complaints, he had hoarseness and alopecia. His neurological examination was normal. He also had bilateral, symmetrical calcification of the hippocampus and parahippocampal regions [Figure 2]. The genetic testing showed ECM-1 gene mutation. EEG did not show any abnormalities.
Figure 2

(a) Bilateral amygdala calcification on an axial T1 sequence. (b) Bilateral amygdala calcification on an axial T1 sequence. (c) Bilateral amygdala calcification on an axial T2 sequence. (d) Bilateral amygdala calcification on a coronal FLAIR sequence

(a) Bilateral amygdala calcification on an axial T1 sequence. (b) Bilateral amygdala calcification on an axial T1 sequence. (c) Bilateral amygdala calcification on an axial T2 sequence. (d) Bilateral amygdala calcification on a coronal FLAIR sequence Valproic acid was the preferred drug for the patients. The seizures were controlled with valproic acid therapy. Urbach--Wiethe disease (also known as lipoid proteinosis; hyalinosis cutis et mucosae) is a rare disorder caused by mutations in ECM-1.[1] ECM-1 is an extracellular protein that takes part in angiogenesis.[1] Autopsy studies have shown calcified vessel walls and gliotic tissues in the amygdala.[1] Bilateral symmetrical temporal lobe calcification can be seen in up to 75% of patients with Urbach--Wiethe disease.[1] Temporal lobe calcifications are visible on T1, T2, and FLAIR images.[1] Epilepsy and behavioral changes are the most common neurological manifestations.[2] The most common seizure type is focal seizures with impaired awareness, which may manifest as motionless staring with an epigastric aura.[2] The neuropsychological findings are aggressive behavior, anxiety, hypersexuality, and decreased ability to identify emotional expressions.[3] The neuropsychological findings and radiologic findings can evolve over time.[13] Valproic acid is one of the effective drugs in temporal lobe epilepsy.[4] Also preferred was valproic acid, so as to take advantage of its impulse control effect.[5] Urbach--Wiethe disease is associated with intracerebral hemorrhage.[67] A small number of Urbach--Wiethe disease patients with intracerebral hemorrhage were reported in the past.[67] Patients may develop a large brain hematoma or small cerebral hemorrhages.[67] The ECM-1 gene is expressed around the vessels.[8] The ECM-1 protein stimulates blood vessel formation.[1] Mutations in the ECM-1 gene cause a glycoprotein deposition and calcium mass in the vessels.[18] Moreover, it reduces collagen protein expression and stimulates the overexpression of non-collagenous proteins.[8] These alterations affect the structure of the vessel walls and may explain the intracerebral hemorrhage risk in patients with Urbach--Wiethe disease.[18] The disease also has a broad range of dermatological and head and neck symptoms.[1] Moniliform blepharosis is pathognomonic.[9] Neurologists should keep Urbach--Wiethe disease in mind due to its neurological manifestations, despite its rarity.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  8 in total

1.  Lipoid proteinosis: a rare disorder with pathognomonic lid lesions.

Authors:  Vidushi Sharma; Seema Kashyap; Subhash M Betharia; Somesh Gupta; Harish Pathak
Journal:  Clin Exp Ophthalmol       Date:  2004-02       Impact factor: 4.207

2.  Amygdalae calcifications associated with disease duration in lipoid proteinosis.

Authors:  Simone Appenzeller; Erik Chaloult; Paulo Velho; Elemir Macedo de Souza; Verônica Zanardi Araújo; Fernando Cendes; Li Min Li
Journal:  J Neuroimaging       Date:  2006-04       Impact factor: 2.486

3.  Spontaneous intracerebral hemorrhage in Urbach-Wiethe disease.

Authors:  Maria Josè Messina; Graziamaria Nuzzaco; Alessandra Barbieri; Marina Scarlato; Simonetta Gerevini; Vittorio Martinelli; Giancarlo Comi; Maria Sessa
Journal:  Neurology       Date:  2012-10-03       Impact factor: 9.910

4.  Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1).

Authors:  Takahiro Hamada; W H Irwin McLean; Michele Ramsay; Gabrielle H S Ashton; Arti Nanda; Trefor Jenkins; Isobel Edelstein; Andrew P South; Oliver Bleck; Vesarat Wessagowit; Rajeev Mallipeddi; Guy E Orchard; Hong Wan; Patricia J C Dopping-Hepenstal; Jemima E Mellerio; Neil V Whittock; Colin S Munro; Maurice A M van Steensel; Peter M Steijlen; Jian Ni; Lurong Zhang; Takashi Hashimoto; Robin A J Eady; John A McGrath
Journal:  Hum Mol Genet       Date:  2002-04-01       Impact factor: 6.150

5.  The Characteristics and Long-Term Course of Epilepsy in Lipoid Proteinosis: A Spectrum From Mild to Severe Seizures in Relation to ECM1 Mutations.

Authors:  Emel Oguz Akarsu; Firdevs Dinçsoy Bir; Can Baykal; Volkan Taşdemir; Bülent Kara; Nerses Bebek; Candan Gürses; Oya Uyguner; Betül Baykan
Journal:  Clin EEG Neurosci       Date:  2017-04-23       Impact factor: 1.843

6.  The neuropsychiatry and neuropsychology of lipoid proteinosis.

Authors:  Helena B Thornton; Daan Nel; Dorothy Thornton; Jack van Honk; Gus A Baker; Dan J Stein
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2008       Impact factor: 2.198

7.  Pharmacologic treatment of impulsive aggression with antiepileptic drugs.

Authors:  Matthew S Stanford; Nathaniel E Anderson; Sarah L Lake; Robyn M Baldridge
Journal:  Curr Treat Options Neurol       Date:  2009-09       Impact factor: 3.598

Review 8.  Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences.

Authors:  Michele Romoli; Petra Mazzocchetti; Renato D'Alonzo; Sabrina Siliquini; Victoria Elisa Rinaldi; Alberto Verrotti; Paolo Calabresi; Cinzia Costa
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.